ebselen has been researched along with Dyskinesia, Medication-Induced in 2 studies
ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burger, ME | 2 |
| Alves, A | 1 |
| Callegari, L | 1 |
| Athayde, FR | 1 |
| Nogueira, CW | 1 |
| Zeni, G | 2 |
| Rocha, JB | 2 |
| Fachinetto, R | 1 |
2 other studies available for ebselen and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Ebselen attenuates reserpine-induced orofacial dyskinesia and oxidative stress in rat striatum.
Topics: Adrenergic Uptake Inhibitors; Animals; Antioxidants; Azoles; Corpus Striatum; Disease Models, Animal | 2003 |
Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain.
Topics: Animals; Antioxidants; Azoles; Behavior, Animal; Brain; Cerebral Cortex; Corpus Striatum; Dyskinesia | 2005 |